Sulfadimethoxine

CHEMBL62193 Phase 4 승인됨 Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
310.3 g/mol
LogP
1.6
Phase
4

Sulfadimethoxine is a long-acting sulfonamide antibiotic used in veterinary medicine for treatment of coccidiosis and various bacterial infections, and historically used in human medicine for urinary tract infections and respiratory infections. Its prolonged half-life allows once-daily or less frequent dosing compared to short-acting sulfonamides. Like all sulfonamides, it inhibits dihydropteroate synthase to block bacterial folate synthesis.

분자량

310.3300 g/mol

LogP

1.60

TPSA

125.00 Ų

리핀스키 5의 법칙

통과

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D 구조

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

COc1cc(NS(=O)(=O)c2ccc(N)cc2)nc(OC)n1

InChI

InChI=1S/C12H14N4O4S/c1-19-11-7-10(14-12(15-11)20-2)16-21(17,18)9-5-3-8(13)4-6-9/h3-7H,13H2,1-2H3,(H,14,15,16)

Molecular Formula

C12H14N4O4S

HBD / HBA

2 / 8

회전 가능 결합

5

무거운 원자

21

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

자주 묻는 질문

Sulfadimethoxine is a long-acting sulfonamide antibiotic used in veterinary medicine for treatment of coccidiosis and various bacterial infections, and historically used in human medicine for urinary tract infections and respiratory infections. Its prolonged half-life allows once-daily or less frequent dosing compared to short-acting sulfonamides. Like all sulfonamides, it inhibits dihydropteroate synthase to block bacterial folate synthesis.

Yes, Sulfadimethoxine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL62193. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 5323. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

의학적 면책조항

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.